Abstract

Modern molecular science, best described as the convergence of (bio)chemistry, molecular biology, physics, and the transformative power of artificial intelligence, is paving the way in design of advanced materials for precision medicine. One of the most promising innovations are bio-nano hybrids, engineered systems that seamlessly integrate biomolecules into synthetic nanostructures to bridge the gap between biology and technology.

In this talk, we will delve into the design principles and biomedical applications of organic and hybrid nanomaterials, with a focus on their role in real-time detection of senescent (aged) cells and the role they play in early cancer detection, and targeted drug delivery.

Beyond the current applications, we will also explore how the next generation of bio-nano tools could redefine the future of biomedical nanotechnology, unlocking new possibilities for disease monitoring, intervention, and treatment. We will also examine the key challenges that must be addressed to streamline the translation pipeline from labs to clinic.